SPRY — ARS PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in ARS PHARMACEUTICALS INC (SPRY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q3)
Avg. % of fund
0.01%
First filed
2023 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 60,000 +30,188 +101.3% 0.00% $603K $10.05
2025 Q3 REDUCED 29,812 -70,688 -70.3% 0.00% $300K $10.05
2025 Q2 REDUCED 100,500 -24,500 -19.6% 0.02% $1.8M $17.45
2024 Q3 ADDED 125,000 +60,300 +93.2% 0.03% $1.8M $14.50
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SPRY price (monthly, adj. close)

Other funds also holding SPRY

As of 2025 Q4 — sorted by position size

SR ONE CAPITAL MANAGEMENT, LP 3Y 6.62% Tyro Capital Management LLC 4.16% ORBIMED ADVISORS LLC 3Y 7Y 1.97% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.3% Casdin Capital, LLC 3Y 7Y 1.16% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.12% Lisanti Capital Growth, LLC 3Y 7Y 1.09% INVESTMENT MANAGEMENT ASSOCIATES INC /ADV 3Y 1.0% Rubric Capital Management LP 3Y 7Y 0.86% LEVIN CAPITAL STRATEGIES, L.P. 3Y 7Y 0.75%
← Back to Caption Management, LLC Holdings